Amyloid Beta Precursor Protein Binding Family A Member 2 (APBA2) Antibody

260€ (50 µl)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Amyloid Beta Precursor Protein Binding Family A Member 2 (APBA2) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx210431
tested applications
ELISA, IHC
Description
APBA2 Antibody is a Rabbit Polyclonal against APBA2.
Documents del producto
Instrucciones
Data sheet
Product specifications
Category | Primary Antibodies |
Immunogen Target | Amyloid Beta Precursor Protein Binding Family A Member 2 (APBA2) |
Host | Rabbit |
Reactivity | Human |
Recommended Dilution | ELISA: 1/2000 - 1/5000, IHC: 1/100 - 1/300. Optimal dilutions/concentrations should be determined by the end user. |
Clonality | Polyclonal |
Conjugation | Unconjugated |
Isotype | IgG |
Purification | Antigen Affinity Chromatography. |
Size 1 | 50 µl |
Size 2 | 100 µl |
Form | Liquid |
Tested Applications | ELISA, IHC |
Buffer | PBS, pH 7.4, containing 0.05% NaN3 and 40% Glycerol. |
Availability | Shipped within 5-10 working days. |
Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
Dry Ice | No |
UniProt ID | Q99767 |
Gene ID | 321 |
Alias | APBA2, D15S1518E, HsT16821, LIN-10, MGC:14091, MINT2, X11-BETA, X11L, amyloid beta precursor protein binding family A member 2 |
Background | Antibody anti-APBA2 |
Status | RUO |
Descripción
APBA2 is a member of the X11 protein family, known for its role in interacting with the amyloid-beta precursor protein (APP). APBA2 is predominantly expressed in neuronal tissues, where it contributes to the regulation of APP trafficking, processing, and stabilization. This protein is involved in modulating amyloid-beta peptide production, a critical factor in Alzheimer’s disease pathology. By binding APP through its phosphotyrosine-binding (PTB) domain, APBA2 helps reduce the formation of amyloid-beta aggregates, which are the hallmark of neurodegeneration. Apart from its role in APP metabolism, APBA2 has been shown to participate in intracellular trafficking, synaptic vesicle function, and neuronal signal transduction pathways. Dysfunction of APBA2 may lead to abnormal APP processing, contributing to increased amyloid-beta deposition, oxidative stress, and neurotoxicity. Studies indicate that APBA2 is crucial for maintaining synaptic plasticity and cognitive functions, and its dysregulation may play a role in Alzheimer’s disease and other neurodegenerative disorders. As a molecular chaperone and stabilizer of APP, APBA2 is being explored as a potential therapeutic target to reduce amyloid plaque burden and preserve neuronal function in neurodegenerative diseases.
Related Products

Human Amyloid-beta Precursor Protein (APP) CLIA Kit
Human Beta-Amyloid Precursor Protein (APP) Chemiluminescent Immunoassay (CLIA) Kit is a Chemiluminescent Immunoassay (CLIA) kit against Beta-Amyloid Precursor Protein (APP).
Ver Producto
Amyloid-beta Precursor Protein (APP) Antibody (FITC)
Amyloid-beta Precursor Protein (APP) Antibody (FITC) is a Rabbit Polyclonal antibody conjugated to FITC against Amyloid-beta Precursor Protein (APP).
Ver Producto
Amyloid Beta Precursor Like Protein 2 (APLP2) Antibody
APLP2 Antibody is a Rabbit Polyclonal against APLP2.
Ver Producto